Search results with tag "Considerations on health technology assessment"

Considerations on Health Technology Assessment in Japan

Credentials and disclaimer David Grainger • 35 years experience in pharmaceutical industry in New Zealand, Australia and the US • Chair of PhRMA International HTA Task Force • Member of Board of Directors, HTA international (HTAi) 2012-2013 • Member of the Access to Medicines Working Group, a high level industry and government medicines policy group appointed by the

  Health, Assessment, Technology, 2013, Considerations, Considerations on health technology assessment